Results 101 to 110 of about 1,868,860 (176)

Healthcare resource utilization and costs among patients with alpha-1 antitrypsin deficiency with liver and/or lung disease: a longitudinal retrospective study in the USA

open access: yesJournal of Comparative Effectiveness Research
Aim: To evaluate all-cause and liver-associated healthcare resource utilization (HCRU) and costs among patients with alpha-1 antitrypsin deficiency (AATD) with liver disease (LD) and/or lung disease (LgD).
May Hagiwara   +7 more
doaj   +1 more source

PMH19: IDENTIFICATION AND ONE-YEAR COSTS OF TREATMENT-RESISTANT DEPRESSION IN A CLAIMS DATA ANALYSIS

open access: bronze, 2001
Patricia K. Corey‐Lisle   +4 more
openalex   +1 more source

PMA5: A RISK ADJUSTMENT METHODOLOGY FOR CLAIMS DATA

open access: bronze, 2001
Philip Wilson, Yilian Yuan, BT Dowse
openalex   +1 more source

Epidemiology and costs of multiple sclerosis in Switzerland: an analysis of health-care claims data, 2011–2015

open access: yesNeuropsychiatric Disease and Treatment, 2017
Eva Blozik,1–3 Roland Rapold,1 Klaus Eichler,4 Oliver Reich1 1Department of Health Sciences, Helsana Group, Zürich, Switzerland; 2Institute of General Practice, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 3Division of ...
Blozik E, Rapold R, Eichler K, Reich O
doaj  

Home - About - Disclaimer - Privacy